CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
May 2nd 2025
New results from a breast cancer-related lymphedema study show the importance of measuring fluid and body composition before treatment begins.
FDA Approves Enhertu for Subset of Patients with Metastatic Breast Cancer
May 5th 2022The FDA’s approval of Enhertu in this setting, according to an expert, marks an important milestone and will allow patients with unresectable or metastatic HER2-positive breast cancer to be treated in an earlier line, with the possibility of delaying disease progression.
Kisqali Combo Allows Patients With Advanced Breast Cancer to Live Longer, With ‘More Quality Time’
May 4th 2022Updated trial results showed that the use of Kisqali plus fulvestrant was associated with an approximate 33% decrease in risk of death for women with HR-positive, HER2-negative advanced breast cancer.
Enhertu Granted Breakthrough Therapy Designation for Unresectable/Metastatic Breast Cancer Treatment
April 28th 2022After Enhertu showed promising clinical trial results, the Food and Drug Administration agreed to speed up the development and review of the drug for certain patients with unresectable or metastatic breast cancer.
Patient Offers Advice on Advocating for Quality of Life, Second Opinions in Metastatic Breast Cancer
April 1st 2022In CURE’s Speaking Out video series, on behalf of Living Beyond Breast Cancer, Myra Camino discusses her experience as a patient advocating for herself after her stage 4 metastatic breast cancer diagnosis.